Theses guys are not full of hype like some company’s are ... they seem to be straight down the line.
So when you get statement like this ...
“These data highlight the key role that FAK plays in the underlying pathophysiology of multiple fibrotic diseases and is expected to open up new development and partnering opportunities for the Company in the future.”
It’s time to take heed ...
.
Theses guys are not full of hype like some company’s are ......
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.8¢ |
Change
-0.012(12.0%) |
Mkt cap ! $24.13M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 8.6¢ | $614.5K | 5.826M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 122997 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 11000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| ATX (ASX) Chart |